Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
6.26
-0.41 (-6.15%)
At close: May 15, 2026, 4:00 PM EDT
6.00
-0.26 (-4.15%)
After-hours: May 15, 2026, 5:19 PM EDT
Shattuck Labs Market Cap
Shattuck Labs has a market cap or net worth of $473.14 million as of May 15, 2026. Its market cap has increased by 814.62% in one year.
Market Cap
473.14M
Enterprise Value
384.76M
1-Year Change
814.62%
Ranking
Category
Stock Price
$6.26
Market Cap Chart
Since the IPO on October 9, 2020, Shattuck Labs's market cap has decreased from $677.31M to $473.14M, a decrease of -30.14%. That is a compound annual growth rate of -6.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 473.14M | 104.85% |
| Dec 31, 2025 | 230.97M | 299.85% |
| Dec 31, 2024 | 57.77M | -82.81% |
| Dec 29, 2023 | 336.08M | 244.71% |
| Dec 30, 2022 | 97.50M | -72.88% |
| Dec 31, 2021 | 359.52M | -83.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XOMA Royalty | 524.72M |
| Contineum Therapeutics | 524.16M |
| ProKidney | 522.39M |
| 4D Molecular Therapeutics | 519.10M |
| Avalo Therapeutics | 513.45M |
| Prothena Corporation | 512.01M |
| Neurogene | 508.35M |
| Ocugen | 492.54M |